A citation-based method for searching scientific literature

Cosette D Champion, Yi Ren, Samantha M Thomas, Oluwadamilola M Fayanju, Laura H Rosenberger, Rachel A Greenup, Carolyn S Menendez, E Shelley Hwang, Jennifer K Plichta. Ann Surg Oncol 2019
Times Cited: 22







List of co-cited articles
103 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
Victoria Sopik, Ping Sun, Steven A Narod. Breast Cancer Res Treat 2018
43
50


Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes.
Milim Kim, Hyun Jeong Kim, Yul Ri Chung, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park. J Breast Cancer 2018
25
40

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Yan Fang, Jiayi Wu, Wei Wang, Xiaochun Fei, Yu Zong, Xiaosong Chen, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li,[...]. Oncotarget 2016
22
31

Microinvasive carcinoma of the breast.
Simonetta Bianchi, Vania Vezzosi. Pathol Oncol Res 2008
54
31

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Rahul R Parikh, Bruce G Haffty, Donald Lannin, Meena S Moran. Int J Radiat Oncol Biol Phys 2012
53
31

Microinvasive breast carcinoma: An analysis from ten Senonetwork Italia breast centres.
Leopoldo Costarelli, Ettore Cianchetti, Fabio Corsi, Daniele Friedman, Matteo Ghilli, MariaTeresa Lacaria, Lorenzo Menghini, Roberto Murgo, Antonio Ponti, Stefano Rinaldi,[...]. Eur J Surg Oncol 2019
14
35

Clinicopathologic analysis of a large series of microinvasive breast cancers.
Tamera J Lillemoe, Michaela L Tsai, Karen K Swenson, Barbara Susnik, Janet Krueger, Kendra Harris, Natasha Rueth, Erin Grimm, Joseph W Leach. Breast J 2018
11
45

Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast.
Li Wang, Wei Zhang, Shuhua Lyu, Xia Liu, Tongxian Zhang, Shan Liu, Ying Qin, Xiaoqi Tian, Yun Niu. Tumour Biol 2015
27
22

Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Ke-Da Yu, La-Mu Wu, Guang-Yu Liu, Jiong Wu, Gen-Hong Di, Zhen-Zhou Shen, Zhi-Ming Shao. Ann Surg Oncol 2011
51
22

Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome.
Cristina C Vieira, Cecilia L Mercado, Joan F Cangiarella, Linda Moy, Hildegard K Toth, Amber A Guth. Eur J Radiol 2010
46
22

Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
F Magnoni, G Massari, G Santomauro, V Bagnardi, E Pagan, G Peruzzotti, V Galimberti, P Veronesi, V S Sacchini. Br J Surg 2019
18
27

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
462
22

Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
Nimmi S Kapoor, Jaime Shamonki, Myung-Shin Sim, Cathie T Chung, Armando E Giuliano. Ann Surg Oncol 2013
32
22

Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
Lamis Shatat, Nika Gloyeske, Rashna Madan, Maura O'Neil, Ossama Tawfik, Fang Fan. Hum Pathol 2013
28
22

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Armando E Giuliano, James L Connolly, Stephen B Edge, Elizabeth A Mittendorf, Hope S Rugo, Lawrence J Solin, Donald L Weaver, David J Winchester, Gabriel N Hortobagyi. CA Cancer J Clin 2017
435
22

Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion.
Zhi-Bin Wan, Hong-Yi Gao, Lian Wei, An-Qin Zhang, Jiang-Yu Zhang, Yi Wang, Dong-Dong Wang, Yan Zhang. Medicine (Baltimore) 2018
11
36


Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
Isabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, Isabelle Soubeyran, Véronique Picot, Jean-Michel Coindre. Cancer 2002
81
18

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
18

Factors predicting microinvasion in Ductal Carcinoma in situ.
Sibel Ozkan-Gurdal, Neslihan Cabioglu, Beyza Ozcinar, Mahmut Muslumanoglu, Vahit Ozmen, Mustafa Kecer, Ekrem Yavuz, Abdullah Igci. Asian Pac J Cancer Prev 2014
32
18

Are microinvasion and micrometastasis in breast cancer mountains or molehills?
S A Hoda, A Chiu, M L Prasad, D Giri, R S Hoda. Am J Surg 2000
24
18

Ductal carcinoma in situ with microinvasion.
Tara L Adamovich, Rache M Simmons. Am J Surg 2003
48
18

Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Danielle N Margalit, Meera Sreedhara, Yu-Hui Chen, Paul J Catalano, Paul L Nguyen, Mehra Golshan, Beth A Overmoyer, Jay R Harris, Jane E Brock. Ann Surg Oncol 2013
35
18

Multiple Microinvasion Foci in Ductal Carcinoma In Situ Is Associated With an Increased Risk of Recurrence and Worse Survival Outcome.
Jing Si, Rong Guo, Huan Pan, Xiang Lu, Zhiqin Guo, Chao Han, Li Xue, Dan Xing, Wanxin Wu, Caiping Chen. Front Oncol 2020
6
66

Long term prognosis of ductal carcinoma in situ with microinvasion: a retrospective cohort study.
Tianjie Pu, Xiaorong Zhong, Ling Deng, Shi Li, Yan Qiu, Yueping Liu, Hong Zheng, Feng Ye, Hong Bu. Int J Clin Exp Pathol 2018
9
33

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
225
13

Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.
Cindy B Matsen, Allison Hirsch, Anne Eaton, Michelle Stempel, Alexandra Heerdt, Kimberly J Van Zee, Hiram S Cody, Monica Morrow, George Plitas. Ann Surg Oncol 2014
28
13

Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Eileen Rakovitch, Rinku Sutradhar, Nafisha Lalani, Sharon Nofech-Mozes, Sumei Gu, Mira Goldberg, Wedad Hanna, Cindy Fong, Lawrence Paszat. Breast Cancer Res Treat 2019
7
42

Axillary node staging for microinvasive breast cancer: is it justified?
John M Lyons, Michelle Stempel, Kimberly J Van Zee, Hiram S Cody. Ann Surg Oncol 2012
26
13

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
34
13

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
118
13

The utility of sentinel lymph node biopsy in patients with ductal carcinoma in situ suspicious for microinvasion on core biopsy.
Jukes P Namm, Jeffrey Mueller, Masha Kocherginsky, Swati Kulkarni. Ann Surg Oncol 2015
13
23

Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.
Serena Bertozzi, Carla Cedolini, Ambrogio P Londero, Barbara Baita, Francesco Giacomuzzi, Decio Capobianco, Marta Tortelli, Alessandro Uzzau, Laura Mariuzzi, Andrea Risaliti. Medicine (Baltimore) 2019
10
30

Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study.
Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov. Breast Cancer Res Treat 2019
7
42

Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series.
Lorenzo Orzalesi, Donato Casella, Valentina Criscenti, Ulpiana Gjondedaj, Simonetta Bianchi, Vania Vezzosi, Jacopo Nori, Lorenzo Cecconi, Icro Meattini, Lorenzo Livi,[...]. Breast Cancer 2016
20
15


Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
221
13

Clinic-Pathological Features of Breast Ductal Carcinoma in Situ with Micro-Invasion.
Jie Zheng, Tao Zhou, Fang Li, Jiajie Shi, Lina Zhang. Cancer Invest 2020
5
60

Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
Anita Mamtani, Faina Nakhlis, Stephanie Downs-Canner, Emily C Zabor, Monica Morrow, Tari A King, Kimberly J Van Zee. Ann Surg Oncol 2019
12
25

Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
Hai-Fei Niu, Li-Juan Wei, Jin-Pu Yu, Zhen Lian, Jing Zhao, Zi-Zheng Wu, Jun-Tian Liu. Cancer Biol Med 2016
8
37

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
406
13

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
245
13

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Shinn Young Kim, Seung-Hyun Jung, Min Sung Kim, In-Pyo Baek, Sung Hak Lee, Tae-Min Kim, Yeun-Jun Chung, Sug Hyung Lee. Oncotarget 2015
50
13

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer.
Wei Zhang, Er-li Gao, Yi-li Zhou, Qi Zhai, Zhang-yong Zou, Gui-long Guo, Guo-rong Chen, Hua-min Zheng, Guan-li Huang, Xiao-hua Zhang. World J Surg Oncol 2012
21
9

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma.
Min Jang, Eun Kim, Yoomi Choi, Hee Lee, Yu Kim, Jee Kim, Eunyoung Kang, Sung-Won Kim, In Kim, So Park. Breast Cancer Res 2012
61
9

Pathological assessment of microinvasive carcinoma of the breast.
Miki Mori, Koichiro Tsugawa, Hideko Yamauchi, Hiroshi Yagata, Koyu Suzuki, Sachiko Ohde, Kumiko Soejima, Seigo Nakamura. Breast Cancer 2013
16
12

Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.
Armando E Giuliano, Stephen B Edge, Gabriel N Hortobagyi. Ann Surg Oncol 2018
229
9

Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion.
Jose M Pimiento, M Catherine Lee, Nicole N Esposito, John V Kiluk, Nazanin Khakpour, W Bradford Carter, Gang Han, Christine Laronga. J Oncol Pract 2011
22
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.